$RAD $CVS $MCK $CAH: Rite Aid Gets Rocked After Cutting Drug Purchasing Efficiencies

Date: Monday, August 6th, 2018

Stock(s) mentioned: , , ,

Source: TheStreet (https://www.thestreet.com)

Summary: Rite Aid’s generic drug purchasing power is likely much lower than previously forecast. What does this mean for CVS? Here are some answers.

Full article address: https://www.thestreet.com/markets/rite-aid-stock-price-cvs-earnings-14674203

Latest News:

$KMB $M $BP $TWLO: How This Selloff Works: Cramer’s ‘Mad Money’ Recap (Wednesday 8/15/18)

$AMZN: Why you should beware of your smartphone—and the invisible blue light it emits

$AMZN $GOOG $AAPL: What your children can teach Alexa

$TSLA: SEC sends subpoena to Tesla in probe over Musk tweets

$TROW $TSLA: The Wall Street Journal: T. Rowe, Fidelity sold more then 20% of their stakes in Tesla last quarter

$INNMF $FB $EFX $GS: What exactly is insider trading—and how do you avoid it?

$BCS $USDTRY: Market Extra: Barclays trader reportedly took a $19 million hit from Turkish bonds

$CSCO $DJIA $SPX $COMP: Cisco stock gains after earnings and outlook top estimates

$T $TJX: This is how the 1% shop for clothes

$CSCO: Cisco Rises After Hours on Strong Guidance, Slight Earnings Beat

$WMT $DJIA $SPX $TGT: Earnings Outlook: Walmart earnings: E-commerce investments could offset earnings growth

Related News:

$PEP $RAD $NWL $TSN $CAH $GS: Stocks Lower as Trade Concerns Remain the Focus

$MCK $CAH $ABC: Congress Sets Opioid Hearing Next Month for Drug Distributors

$CAH $TGT $XOM $T $WBA: How to Avoid Going Broke in Retirement

$MCK $ABC $CAH $AGN $MYL: McKesson’s Lawsuit Puts PBMs Back Into Harsh Public Spotlight